Teladoc slips after reporting earnings miss, slowing revenue
Teladoc sank more than 6% in after-hours trading after it reported earnings that missed Wall Street estimates.
The company reported a loss per share of $0.53, compared to the $0.34 loss per share analysts polled by FactSet were expecting. It reported $629.4 million in revenue, more than the $619.2 million analysts were expecting, but down from the $646 million it reported during the same period last year. Teladoc has seen revenue decline since its pandemic-era boom.
The company left its guidance for revenue untouched but said it now expects an annual loss per share of $0.90 to $1.40, up from its previous guidance of $0.50 to $1.10. That guidance does not price in any impact from tariffs.
Teladoc also announced on Wednesday that it would acquire UpLift, a mental health and psychiatry startup, for $30 million.
Correction (April 30, 4:50 p.m. ET) : Corrected spelling of Teladoc in headline and chart.